MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Speech, gait and vestibular instrumental assessment in CANVAS: a case series.

    G. Di Rauso, F. Cavallieri, V. Fioravanti, E. Monfrini, A. Gessani, I. Campanini, A. Merlo, A. Castellucci, D. Ronchi, M. Napoli, R. Pascarella, S. Grisanti, R. Sabadini, C. Zini, A. Di Fonzo, F. Valzania (Modena, Italy)

    Objective: To describe through a systematic clinical-instrumental approach speech, gait and vestibular alterations in cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Background: CANVAS…
  • 2023 International Congress

    A new era in etiologies of chorea

    D. Biederko, M. Bennun Caller, L. Franken, R. Djaldetti (Petah Tikva, Israel)

    Objective: To describe the prevalence, presentation and etiology of chorea (including ballism and athetosis) in adults as seen at a tertiary medical center in Israel…
  • 2023 International Congress

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

    H. Berven, S. Kverneng, E. Sheard, M. Søgnen, S. Geijerstam, K. Haugarvoll, GO. Skeie, C. Dölle, C. Tzoulis (Bergen, Norway)

    Objective: To determine the safety of oral nicotinamide riboside (NR) 3000 mg daily for 4 weeks in Parkinson’s disease (PD). Secondary objectives: To assess NRs…
  • 2023 International Congress

    Expiratory strength in Parkinson’s disease patients? Does time matter?

    R. Guimaraes, F. Cendes, L. Paiva, MF. Satollo, M. Diogo, L. Durans (Campinas, Brazil)

    Objective: To assess the effectiveness of cough in Parkinson’s Disease (PD) patients in mild, moderate and severe disease stages. Background: Parkinson's Disease is the second…
  • 2023 International Congress

    Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India

    S. Kamath, V. Holla, P. Phulpagar, N. Kamble, R. Yadav, B. Muthusamy, PK. Pal (Bangalore, India)

    Objective: To describe the clinico-genetic association of PD patients with heterozygous GBA mutations (PDwG). Background: Parkinson’s disease (PD) is currently understood to be the outcome…
  • 2023 International Congress

    A Retrospective Review of Amantadine in Progressive Supranuclear Palsy

    N. Mcfarland, R. Farrukh, S. Mahn (Gainesville, USA)

    Objective: To determine the efficacy and tolerability of amantadine in Progressive supranuclear palsy (PSP). Background: PSP is one of the most common atypical parkinsonian disorders,…
  • 2023 International Congress

    Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

    Objective: To analyse the gut microbiome and explore dysbiosis in Indian Parkinson’s Disease patients with and without constipation. Background: Global studies have associated gut dysbiosis…
  • 2023 International Congress

    Potential role of Alpha-synuclein levels in Platelets in GBA-related PD

    G. Uras, S. Lucas, A. Schapira (London, United Kingdom)

    Objective: Identification of a blood biomarker to predict PD diagnosis or to monitor the disease progression. Background: Previous evidence suggests differences in systemic alpha-synuclein levels…
  • 2023 International Congress

    The neuroprotective miRNA family hsa-miR-451 has a distinctive pattern of downregulation in neurodegenerative diseases.

    R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: 1.Identification of microRNAs from whole blood PBMCs of SCA2 patients by using NGS.    2.To check the exclusivity of miRNAs in SCA2, SCA1,SCA3,SCA12,HD,ALS,PD and MSA-C…
  • 2023 International Congress

    Characterization of haemodynamic activity in resting-state networks associated with cognitive decline in PD: a fractal analysis approach

    E. Fiorenzato, A. Antonini, L. Weis, R. Biundo, V. D’Onofrio, F. Ferreri, S. Moaveninejad, C. Porcaro (Padova, Italy)

    Objective: To characterize the frequency dependence and the complexity changes of functional connectivity associated with PD cognitive decline. Background: Changes in spontaneous neural activity have…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley